MyHealthchecked (MHC)

Sector:

Health Care

Index:

FTSE AIM All-Share

2.70p
   
  • Change Today:
    -0.35p
  • 52 Week High: 6.70
  • 52 Week Low: 1.30
  • Currency: UK Pounds
  • Shares Issued: 756.09m
  • Volume: 1,598,976
  • Market Cap: £20.41m
  • RiskGrade: 796
  • Beta: 0.05

Concepta acquires outstanding shares in The Genome Store

By Iain Gilbert

Date: Monday 23 Nov 2020

LONDON (ShareCast) - (Sharecast News) - Healthcare company Concepta has acquired 100% of the outstanding share capital of The Genome Store in a deal worth as much as £520,000.
Concepta will make an initial consideration of £280,000 in shares for the provider of home-administered postal genomic test services, with a deferred consideration of up to £240,00 payable in shares subject to agreed performance milestones being met.

The AIM-listed group stated the acquisition delivered upon one of the group's key strategic areas of focus, namely growing its product portfolio into other areas of personalised health and female health products.

Concepta highlighted that the genomic testing service provided a complementary portfolio of products to its personalised fertility tracker.

Chief executive Penny Mccormick said: "As the testing horizon changes, we look forward to working with our new team in the expansion and launch of our initial development pipeline.

"We remain committed to the development of connected technology through our fertility testing platform, whilst adding to our portfolio to support personalised family health."

As of 1000 GMT, Concepta shares had shot up 19.44% to 1.08p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MyHealthchecked Market Data

Currency UK Pounds
Share Price 2.70p
Change Today -0.35p
% Change -11.48 %
52 Week High 6.70
52 Week Low 1.30
Volume 1,598,976
Shares Issued 756.09m
Market Cap £20.41m
Beta 0.05
RiskGrade 796

MyHealthchecked Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
77.68% below the market average77.68% below the market average77.68% below the market average77.68% below the market average77.68% below the market average
88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average88.89% below the sector average
Price Trend
33.79% above the market average33.79% above the market average33.79% above the market average33.79% above the market average33.79% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Income Not Available
Growth
22.77% above the market average22.77% above the market average22.77% above the market average22.77% above the market average22.77% above the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average

MyHealthchecked Dividends

No dividends found

Trades for 01-Dec-2021

Time Volume / Share Price
08:18 70,000 @ 2.62p
08:18 244,266 @ 2.65p
08:18 66,666 @ 2.75p
08:18 200,000 @ 2.75p
08:17 29,412 @ 2.72p

MyHealthchecked Key Personnel

CEO Penelope McCormick

Top of Page